Skip to content
★ Sign in to follow
JB

Jade Brown

CTI Biopharma Corp
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€28k

Latest filing published 30 Oct 2006 for CTI Biopharma CORP.

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

No signal scores available.

Jade Brown: trading record in brief

Jade Brown is a declared insider of CTI Biopharma Corp, with filings sourced from SEC (Form 4). Over a trading history stretching from 31 March 2006 to 26 October 2006, the count stands at 16 filings.

On the market, this insider has only sold: 15 sales, €28k in total.

The record was last updated on 30 October 2006 with a transaction in CTI Biopharma Corp. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Jade Brown

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ●
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    0SEC
    57,329 shares0Common StockSEC:0000891293-06-000024:0
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    552 USD0SEC
    400 shares@ US$1.38Common StockSEC:0000891293-06-000019:0
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    556 USD0SEC
    400 shares@ US$1.39Common StockSEC:0000891293-06-000019:1
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    2,520 USD0SEC
    1,800 shares@ US$1.40Common StockSEC:0000891293-06-000019:2
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    3,948 USD0SEC
    2,800 shares@ US$1.41Common StockSEC:0000891293-06-000019:3
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    4,828 USD0SEC
    3,400 shares@ US$1.42Common StockSEC:0000891293-06-000019:4
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    858 USD0SEC
    600 shares@ US$1.43Common StockSEC:0000891293-06-000019:5
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    144 USD0SEC
    100 shares@ US$1.44Common StockSEC:0000891293-06-000019:6
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    2,698 USD0SEC
    1,900 shares@ US$1.42Common StockSEC:0000891293-06-000014:0
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    3,432 USD0SEC
    2,400 shares@ US$1.43Common StockSEC:0000891293-06-000014:1
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    1,872 USD0SEC
    1,300 shares@ US$1.44Common StockSEC:0000891293-06-000014:2
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    4,964 USD0SEC
    3,400 shares@ US$1.46Common StockSEC:0000891293-06-000014:3
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    2,352 USD0SEC
    1,600 shares@ US$1.47Common StockSEC:0000891293-06-000014:4
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    1,924 USD0SEC
    1,300 shares@ US$1.48Common StockSEC:0000891293-06-000014:5
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    894 USD0SEC
    600 shares@ US$1.49Common StockSEC:0000891293-06-000014:6
  • ▼
    EVP, Chief Business OfficerExecutivesCTI Biopharma Corp
    2,940 USD0SEC
    1,500 shares@ US$1.96Common StockSEC:0000891293-06-000004:0

16 of 16 declarations